Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
ADORE: Samenwerken om kanker en hersenziekten beter te bestrijden
okt 2022 | Dementie, Immuuntherapie